Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

In Vitro Susceptibility of Typhoidal, Nontyphoidal, and Extended-Spectrum-β-Lactamase-Producing Salmonella to Ceftolozane/Tazobactam.

  • Authors : Teng JLL; Department of Microbiology, The University of Hong Konggrid.194645.b, Hong Kong, China.; Chan E

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology ; Drug Resistance, Bacterial* ; Penicillanic Acid*

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Jan 18; Vol. 66 (1), pp. e0122421. Date of Electronic Publication: 2021 Oct Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain.

  • Authors : Sime FB; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; School of Pharmacy, Centre for Translational Anti-Infective Pharmacodynamics, The University of Queensland, Brisbane, Australia.

Subjects: Critical Illness* ; Penicillanic Acid*/Penicillanic Acid*/Penicillanic Acid*/therapeutic use; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/therapeutic use

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2020 Dec 16; Vol. 65 (1). Date of Electronic Publication: 2020 Dec 16 (Print Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

×
Academic Journal

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model.

  • Authors : VanScoy BD; Institute for Clinical Pharmacodynamics, Schenectady, New York, USA.; Tenero D

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Cephalosporins/Cephalosporins/Cephalosporins/*pharmacology ; Escherichia coli/Escherichia coli/Escherichia coli/*drug effects

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Nov 22; Vol. 61 (12). Date of Electronic Publication: 2017 Nov 22 (Print Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

×
Academic Journal

Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.

  • Authors : Monogue ML; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.; Stainton SM

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacokinetics ; Cephalosporins/Cephalosporins/Cephalosporins/*pharmacokinetics ; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*drug therapy

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Nov 22; Vol. 61 (12). Date of Electronic Publication: 2017 Nov 22 (Print Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

×
Academic Journal

Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.

  • Authors : Sime FB; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Australia .; Therapeutics Research Centre, School of Pharmacy, The University of South Australia, Adelaide, Australia.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Bacterial Infections/Bacterial Infections/Bacterial Infections/*drug therapy ; Febrile Neutropenia/Febrile Neutropenia/Febrile Neutropenia/*drug therapy

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Oct 24; Vol. 61 (11). Date of Electronic Publication: 2017 Oct 24 (Print Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

×
Academic Journal

Influence of β-Lactam Infusion Strategy on Acute Kidney Injury.

  • Authors : Cotner SE; University of Kentucky HealthCare, Lexington, Kentucky, USA.; Rutter WC

Subjects: Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*chemically induced ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*adverse effects ; Cephalosporins/Cephalosporins/Cephalosporins/*adverse effects

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Sep 22; Vol. 61 (10). Date of Electronic Publication: 2017 Sep 22 (Print Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

×
Academic Journal

Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients.

  • Authors : Alobaid AS; Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Queensland, Australia.; Department of Pharmacy, King Saud Medical City, Riyadh, Saudi Arabia.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacokinetics ; Bacterial Infections/Bacterial Infections/Bacterial Infections/*drug therapy ; Obesity, Morbid/Obesity, Morbid/Obesity, Morbid/*drug therapy

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Feb 23; Vol. 61 (3). Date of Electronic Publication: 2017 Feb 23 (Print Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

×
Academic Journal

Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.

  • Authors : Rutter WC; University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.; University of Kentucky HealthCare, Lexington, Kentucky, USA.

Subjects: Cephalosporins/Cephalosporins/Cephalosporins/*adverse effects ; Penicillanic Acid/Penicillanic Acid/Penicillanic Acid/*analogs & derivatives ; Vancomycin/Vancomycin/Vancomycin/*adverse effects

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Jan 24; Vol. 61 (2). Date of Electronic Publication: 2017 Jan 24 (Print Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

×
Academic Journal

Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases.

  • Authors : Sabbagh Y; Microbiologie Moléculaire et Génie des Protéines, Sciences de la Vie et de la Santé, Faculté de Médecine, Université Laval, Ste-Foy, Québec, Canada G1K 7P4.; Thériault E

Subjects: beta-Lactamase Inhibitors*; Enzyme Inhibitors/Enzyme Inhibitors/Enzyme Inhibitors/*pharmacology ; Penicillanic Acid/Penicillanic Acid/Penicillanic Acid/*analogs & derivatives

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 1998 Sep; Vol. 42 (9), pp. 2319-25.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be.

Subjects: beta-Lactamase Inhibitors*; Bacteria/Bacteria/Bacteria/*drug effects ; Penicillanic Acid/Penicillanic Acid/Penicillanic Acid/*analogs & derivatives

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 1997 Feb; Vol. 41 (2), pp. 475-7.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  320 results for ""Penicillanic Acid""